Screening of GPCR drugs for repurposing in breast cancer

Drug repurposing can overcome both substantial costs and the lengthy process of new drug discovery and development in cancer treatment. Some Food and Drug Administration (FDA)-approved drugs have been found to have the potential to be repurposed as anti-cancer drugs. However, the progress is slow du...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdulkareem, Noor Mazin, Bhat, Raksha, Powell, Reid T., Chikermane, Soumya, Yande, Soham, Trinh, Lisa, Abdelnasser, Hala Y., Tabassum, Mantasha, Ruiz, Alexis, Sobieski, Mary, Nguyen, Nghi D., Park, Jun Hyoung, Johnson, Camille A., Kaipparettu, Benny A., Bond, Richard A., Johnson, Michael, Stephan, Clifford, Trivedi, Meghana V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763283/
https://www.ncbi.nlm.nih.gov/pubmed/36561339
http://dx.doi.org/10.3389/fphar.2022.1049640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763283/
https://www.ncbi.nlm.nih.gov/pubmed/36561339
http://dx.doi.org/10.3389/fphar.2022.1049640

Ejemplares similares